AAPM 2012

AAPM 2012

Study Provides Evidence of Milnacipran Efficacy for the Long-Term Treatment of Fibromyalgia

A study that evaluated the effect of discontinuing long-term treatment with milnacipran on the symptoms of fibromyalgia found that once the agent was withdrawn, time to loss of therapeutic response was significantly shorter than in patients who continued treatment, investigators reported during the 2012 American Academy of Pain Medicine Annual Meeting.

For Children with Chronic Pain, Evaluation Requires a Biopsychosocial Model

Increasing survival rates for premature infants—in which pain in neonates can change the developing sensory nervous system, increasing the risk for long-term chronic pain—and increasing survival of children with genetics diseases both contribute to chronic pain in children, Lonnie K. Zeltzer, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA, told those attending the 2012 American Academy of Pain Medicine Annual Meeting.

Myofascial Pain: Treat the Cause, Not the Symptom

Myofascial pain syndrome affects up to 95% of people with chronic pain disorders and approximately 9 million Americans suffer from myofascial pain, with underlying factors that include overuse syndromes, trauma, and spinal pathologies, Mehul J. Desai, MD, MPH, George Washington University Hospital, Washington, DC, told attendees during the 2012 American Academy of Pain Medicine Annual Meeting.